Immunome, Inc. (IMNM)
20.88
-1.14
(-5.18%)
USD |
NASDAQ |
May 15, 16:00
20.90
+0.02
(+0.10%)
After-Hours: 20:00
Immunome EPS Diluted (Quarterly) : -0.4759 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.833 |
| Scholar Rock Holding Corp. | -0.829 |
| Stoke Therapeutics, Inc. | -0.7929 |
| Nurix Therapeutics, Inc. | -0.792 |
| Exelixis, Inc. | 0.7873 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -53.84M |
| Total Expenses (Quarterly) | 53.84M |
| Enterprise Value | 1.786B |
| Earnings Yield | -11.40% |
| Normalized Earnings Yield | -11.04 |